Drug Trial Radar · NCT07533942
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Jul 16, 2026
Primary completion
Oct 25, 2028
Study completion Oct 16, 2031
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- Collaborators
- Chimerix, Inc.
- First posted
- Apr 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will recruit participants with Grade 2 and 3 meningiomas who have failed prior therapy. Participants will receive oral doses of JZP3507. The antitumor activity and safety of JZP3507 will be evaluated.
Conditions
- Meningioma
Interventions
JZP3507Drug
Participants will receive oral JZP3507 monotherapy twice daily, on 3 consecutive days per week in 28-day cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate (ORR) as Assessed by Response Assessment in Neuro-Oncology (RANO) Criteria and Evaluated by Blinded Independent Central Review (BICR)Time frame: From first dose until death, withdrawal of consent, or lost to follow-up, up to 36 months.
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Sutter Health
San Francisco, California · Recruiting
Yale-New Haven Hospital - Yale Cancer Center
New Haven, Connecticut · Recruiting
Indiana University Health Neurosurgery Clinic
Indianapolis, Indiana · Recruiting
Louisiana State University
New Orleans, Louisiana · Recruiting
Mass General
Boston, Massachusetts · Not yet recruiting
NYU- Langone Health
New York, New York · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
University of Utah - Huntsman Cancer Institute
Salt Lake City, Utah · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.